292 related articles for article (PubMed ID: 11356386)
21. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
22. Treatment of true bifurcation stenosis by elective stent implantation in parent vessel and non-stent dilatation of side branch: immediate and follow-up results.
Gambhir DS; Singh S; Sinha SC; Nair GM; Arora R
Indian Heart J; 2000; 52(3):289-96. PubMed ID: 10976149
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main coronary bifurcation disease in the drug-eluting stent era.
Chang K; Koh YS; Jeong SH; Lee JM; Her SH; Park HJ; Kim PJ; Kim YH; Chung WS; Yim HW; Park SJ; Seung KB
Heart; 2012 May; 98(10):799-805. PubMed ID: 22422589
[TBL] [Abstract][Full Text] [Related]
24. Relation of percutaneous coronary intervention of complex lesions to clinical outcomes (from the NHLBI Dynamic Registry).
Wilensky RL; Selzer F; Johnston J; Laskey WK; Klugherz BD; Block P; Cohen H; Detre K; Williams DO
Am J Cardiol; 2002 Aug; 90(3):216-21. PubMed ID: 12127606
[TBL] [Abstract][Full Text] [Related]
25. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
26. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
[TBL] [Abstract][Full Text] [Related]
27. Impact of bifurcation stent technique on clinical outcomes in patients with a Medina 0,0,1 coronary bifurcation lesion: results from the COBIS (COronary BIfurcation Stenting) II registry.
Jang WJ; Song YB; Hahn JY; Choi SH; Kim HS; Yu CW; Rha SW; Jang Y; Seung KB; Gwon HC
Catheter Cardiovasc Interv; 2014 Nov; 84(5):E43-50. PubMed ID: 24659259
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
[TBL] [Abstract][Full Text] [Related]
29. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery.
Takagi T; Stankovic G; Finci L; Toutouzas K; Chieffo A; Spanos V; Liistro F; Briguori C; Corvaja N; Albero R; Sivieri G; Paloschi R; Di Mario C; Colombo A
Circulation; 2002 Aug; 106(6):698-702. PubMed ID: 12163430
[TBL] [Abstract][Full Text] [Related]
30. Choice of stenting strategy in true coronary artery bifurcation lesions.
Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
[TBL] [Abstract][Full Text] [Related]
31. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial.
Berland J; Lefèvre T; Brenot P; Fajadet J; Motreff P; Guerin P; Dupouy P; Schandrin C;
EuroIntervention; 2015 Dec; 11(8):868-76. PubMed ID: 26696455
[TBL] [Abstract][Full Text] [Related]
32. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial.
Grundeken MJ; Garcia-Garcia HM; Kumsars I; Lesiak M; Kayaert P; Dens J; Stella PR; de Winter RJ; Laak LL; Généreux P; Kaplan AV; Leon MB; Wykrzykowska JJ; Onuma Y; Serruys PW
Catheter Cardiovasc Interv; 2017 Feb; 89(2):E53-E63. PubMed ID: 27083384
[TBL] [Abstract][Full Text] [Related]
33. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis.
Magro M; Wykrzykowska J; Serruys PW; Simsek C; Nauta S; Lesiak M; Stanislawska K; Onuma Y; Regar E; van Domburg RT; Grajek S; Geuns RJ
Catheter Cardiovasc Interv; 2011 May; 77(6):798-806. PubMed ID: 20824767
[TBL] [Abstract][Full Text] [Related]
34. Long-term treatment effect and adverse events of a modified jailed-balloon technique for side branch protection in patients with coronary bifurcation lesions.
Zhang W; Ji F; Yu X; Wang X
BMC Cardiovasc Disord; 2019 Jan; 19(1):12. PubMed ID: 30630420
[TBL] [Abstract][Full Text] [Related]
35. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry.
Robertson T; Kennard ED; Mehta S; Popma JJ; Carrozza JP; King SB; Holmes DR; Cowley MJ; Hornung CA; Kent KM; Roubin GS; Litvack F; Moses JW; Safian R; Desvigne-Nickens P; Detre KM
Am J Cardiol; 1997 Nov; 80(10A):26K-39K. PubMed ID: 9409690
[TBL] [Abstract][Full Text] [Related]
36. A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry.
Agostoni P; Foley D; Lesiak M; Belkacemi A; Dens J; Kumsars I; Scott B; Oemrawsingh P; Dubois C; Garcia E; Lefèvre T; Stella PR
EuroIntervention; 2012 Mar; 7(11):1293-300. PubMed ID: 22433192
[TBL] [Abstract][Full Text] [Related]
37. One Versus 2-stent Strategy for the Treatment of Bifurcation Lesions in the Context of a Coronary Chronic Total Occlusion. A Multicenter Registry.
Baeza Garzón F; Pan Álvarez-Ossorio M; Romero Moreno MÁ; Martín Palanco V; Herrera Arroyo C; Suárez de Lezo Cruz Conde J
Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):344-350. PubMed ID: 29097079
[TBL] [Abstract][Full Text] [Related]
38. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.
Garot P; Lefèvre T; Savage M; Louvard Y; Bamlet WR; Willerson JT; Morice MC; Holmes DR
J Am Coll Cardiol; 2005 Aug; 46(4):606-12. PubMed ID: 16098423
[TBL] [Abstract][Full Text] [Related]
39. Impact of bifurcation lesions on clinical outcome and prognosis of primary angioplasty in acute myocardial infarction.
Abdel-Hakim DE; Garot P; Champagne S; Maklady F; el-Hawary A; Dubois-Randé JL; Lesault PF; Teiger E
EuroIntervention; 2008 May; 4(1):93-8. PubMed ID: 19112785
[TBL] [Abstract][Full Text] [Related]
40. Independent predictors of restenosis after percutaneous coronary revascularization in haemodialysis patients.
Hase H; Nakamura M; Joki N; Tsunoda T; Nakamura R; Saijyo T; Morishita M; Yamaguchi T
Nephrol Dial Transplant; 2001 Dec; 16(12):2372-7. PubMed ID: 11733629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
